| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 16 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 3 | CARBOPLATIN | 11 |
| 4 | DOXORUBICIN | 9 |
| 5 | CYTARABINE | 8 |
| 6 | RITUXIMAB | 7 |
| 7 | METHOTREXATE | 6 |
| 8 | METHOTREXATE SODIUM | 6 |
| 9 | PREDNISONE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 1 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 2 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 1 | 0.0005 |
| 3 | DACTINOMYCIN | 1 | 0.0005 |
| 4 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 5 | PENICILLIN G | 1 | 0.0004 |
| 6 | TOPOTECAN | 2 | 0.0003 |
| 7 | TRETINOIN | 2 | 0.0002 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 9 | ZIDOVUDINE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 18 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| 2 | Corticosteroid [EPC] | 11 |
| 3 | Platinum-based Drug [EPC] | 11 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 7 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 5 |
| 7 | Microtubule Inhibitor [EPC] | 5 |
| 8 | Mood Stabilizer [EPC] | 4 |
| 9 | Proteasome Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 1 | 0.0005 |
| 1 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 2 | Antimalarial [EPC] | 1 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 18 | 0.0001 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 5 | 0.0001 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 12 | 0.0000 |